Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD Announces Proposed Public Offering of Common Stock

GlobeNewswire June 12, 2019

iCAD Reports First Quarter 2019 Financial Results

GlobeNewswire May 7, 2019

iCAD Appoints R. Scott Areglado as Chief Financial Officer

GlobeNewswire May 6, 2019

iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7

GlobeNewswire May 1, 2019

iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System

GlobeNewswire April 15, 2019

iCAD to Highlight ProFound AI™ Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium

GlobeNewswire April 4, 2019

iCAD Appoints Stacey Stevens as President

GlobeNewswire March 28, 2019

iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit

GlobeNewswire March 26, 2019

iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results

GlobeNewswire March 18, 2019

iCAD Reports Strong Momentum of ProFound AI™, its Artificial Intelligence-Based Solution for Digital Breast Tomosynthesis

Business Wire March 14, 2019

iCAD to Present Corporate Overview at the 31st Annual ROTH Conference

GlobeNewswire March 14, 2019

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

GlobeNewswire March 13, 2019

iCAD to Partner with Leading Breast Cancer Researchers from Karolinska Institutet to Develop Artificial Intelligence-Based Breast Cancer Risk Prediction Solution

GlobeNewswire February 27, 2019

iCAD to Showcase ProFound AI™ Solution for Digital Breast Tomosynthesis at ECR 2019

GlobeNewswire February 21, 2019

Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

GlobeNewswire January 7, 2019

Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer

GlobeNewswire January 3, 2019

iCAD Announces CFO Transition

GlobeNewswire December 27, 2018

iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures

GlobeNewswire December 20, 2018

iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis

GlobeNewswire December 7, 2018

iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018

GlobeNewswire November 26, 2018